600 Patients with Malignant Obstructive Jaundice Treated by Percutaneous Transhepatic Cholangial Drainage and Metallic Stent

王洪波,宫梅,崔屹,张安忠,马铭泽,张俊勇
DOI: https://doi.org/10.3969/j.issn.1002-266x.2010.25.005
2010-01-01
Abstract:Objective To observe the effect of percutaneous transhepatic cholangial drainage(PTCD) treatment of malignant obstructive jaundice with metallic stent.Methods All of 600 malignant obstructive jaundice patients,including cholangiocarcinoma in 261 cases,pancreatic head cancer in 109 cases,hepatoma in 107 cases,carcinoma of gallbladder in 25 cases and recurrent gastric carcinoma in 43 cases,metastatic tumors of the liver in 43 cases,carcinoma of Vater ampulla in 12 cases,were treated by PTCD with metallic stent.Results The technical successful rate was 100%.2 cases with biliary tract bleeding after release of the metallic stent with PTCD on 2 hours were controlled by effective clinical treatment.5 cases with biliary tract infection after release of the stent were also controlled by effective clinical treatment.Other cases had no severe complications.After operation,the living periods of patients were 2.5-24 months,average was 6.5 months.The 298 cases were alive more than half a year.Obstructive jaundice reappeared after release of stent in 6,7 and 12 months in 129 patients.Conclusions Treating obstructive jaundice with PTCD and metallic stent is relatively simple and effective.It is a better method for treating malignant obstructive jaundice.
What problem does this paper attempt to address?